Table 7 Molecular diagnostics device global market shares by company [3]
From: The market trend analysis and prospects of cancer molecular diagnostics kits
Company | Market Share |
|---|---|
Roche | 25.20% |
Hologic | 14.40% |
Qiagen | 11.60% |
BD | 9.20% |
Abbott | 8.40% |
Cepheid | 5.50% |
Siemens | 5.20% |
Others | 20.50% |
Total | 100.00% |